Picture of ImpediMed logo

IPD ImpediMed Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for ImpediMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-15.5-17.3-13.8-18.8-19.7
Other Operating Cash Flow
Cash from Operating Activities-19.6-19.2-13.3-15.7-18
Capital Expenditures-2.22-2.16-2.46-5.22-6.04
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.4590
Sale of Business
Cash from Investing Activities-1.76-2.16-2.46-5.22-6.04
Financing Cash Flow Items-0.018-2.68-0.133-2.21-1.67
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.14530.216.539.927.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-208.330.018214.98